Rani Therapeutics Holdings, Inc. - Class A
News
Rani Therapeutics Holdings, Inc.'s (NASDAQ:RANI) market cap dropped US$17m last week; Retail investors bore the brunt
Simply Wall St Key Insights The considerable ownership by retail investors in Rani Therapeutics Holdings indicates that they...\n more…
Rani Therapeutics to Participate in September Investor Conferences
Globe Newswire SAN JOSE, Calif., Sept. 03, 2024 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. ( Rani Therapeutics or Rani ) (Nasdaq: RANI), a clinical-stage biotherapeutics company focused on the oral...\n more…
Vanguard Group Inc. Has $2.13 Million Holdings in Rani Therapeutics Holdings, Inc. (NASDAQ:RANI)
Ticker Report Vanguard Group Inc. lifted its holdings in Rani Therapeutics Holdings, Inc. (NASDAQ:RANI - Free Report) by 2.5% during the 1st quarter, according to its most recent filing with the Securities and...\n more…
Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) Receives Consensus Rating of "Buy" from Analysts
Ticker Report Rani Therapeutics Holdings, Inc. (NASDAQ:RANI - Get Free Report) has earned a consensus recommendation of "Buy" from the eight research firms that are currently covering the firm, Marketbeat reports...\n more…
Rani Therapeutics Holdings, Inc. Expected to Earn FY2024 Earnings of ($1.10) Per Share (NASDAQ:RANI)
Ticker Report Rani Therapeutics Holdings, Inc. (NASDAQ:RANI - Free Report) - Stock analysts at Zacks Small Cap upped their FY2024 EPS estimates for shares of Rani Therapeutics in a report issued on Monday, August...\n more…
Brokerages Set Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) PT at $12.29
Ticker Report Shares of Rani Therapeutics Holdings, Inc. (NASDAQ:RANI - Get Free Report) have been assigned an average recommendation of "Buy" from the seven research firms that are currently covering the company...\n more…